Health Condition 1: L811- Chloasma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: -Clinically diagnosed patients of bilateral facial Kalaf and confirmed by dermoscope -Epidermal and mixed melasma based on dermoscope
Exclusion criteria
Exclusion criteria: -Already diagnose systematic and skin allergic diseases -Skin sensitivity 1-4 type by Fitzpatrick skin type -Pregnant and lactating women -Hypersensitivity reaction to Hydroquinone -Use of Hydroquinone and other anti-tyrosinase drugs within 3 months from baseline -History of chemical peels and facial laser treatment within 9 months and use of sun protector creams
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in mMASI(Modified Melasma Area Severity Index)Timepoint: Baseline, 2nd week, 4th week, 6th week, 8th week | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in Investigatorâ??s Global Assessment For Melasma Severity on 100mm VAS. Change in Patientâ??s Global Assessment (PtGA). Change in Dermatology Life Quality Index (DLQI)Timepoint: Baseline, 2nd week, 4th week, 6th week, 8th week | — |
Countries
India
Contacts
Luqman Unani Medical College,Hospital and Research Centre